Mehmet Karakus, PhD

Health Sciences University, Department of Medical Microbiology, Turkey

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-1226) Dose Optimization of β-lactams against Carbapenem-Resistant Pseudomonas from Turkiye Defined as Susceptible to Ceftazidime, Cefepime or Piperacillin/Tazobactam
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT